Public · NASDAQ:MBOTSurgical/Medical
Hingham, USA
Microbot Medical
Maker of LIBERTY, the first FDA-cleared single-use robotic system for endovascular procedures.
microbotmedical.com$73M
Market cap
#291
Rank on board
2010
Founded
Profile
| Sector | Surgical robots |
|---|---|
| Value chain | Integrator |
| Flagship | LIBERTY |
| Headquarters | |
| Ticker | NASDAQ:MBOT |
| Market cap | $73M (as of 2026-11-03). Source: StockAnalysis |
Regulatory record
FDA clearances: 1
First 4 Sep 2025, latest 4 Sep 2025. Every 510(k) and De Novo filed under the company's name.
- LIBERTY Endovascular Robotic System (LIBERTYOS)4 Sep 2025 · K243789 · System, Catheter Control, Steerable (DXX) · Applicant: Microbot Medical , Ltd.
Source: FDA 510(k) database via openFDA, searched by applicant name, with partners and spun-off businesses removed. PMA approvals are not listed here.
Peers in Surgical/Medical
Company data updated 2026-11-16. All robot companies →